Selenomethionine preconditioned mesenchymal stem cells derived extracellular vesicles exert enhanced therapeutic efficacy in intervertebral disc degeneration
Open Access
- 8 April 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 132, 112028
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (U1304804)
This publication has 59 references indexed in Scilit:
- Small extracellular vesicles from hypoxic mesenchymal stem cells alleviate intervertebral disc degeneration by delivering miR-17-5pActa Biomaterialia, 2022
- Extracellular vesicles from mesenchymal stromal cells: Therapeutic perspectives for targeting senescence in osteoarthritisAdvanced Drug Delivery Reviews, 2021
- Extracellular Vesicles as an Emerging Treatment Option for Intervertebral Disc Degeneration: Therapeutic Potential, Translational Pathways, and Regulatory ConsiderationsAdvanced Healthcare Materials, 2021
- Peptide-based supramolecular hydrogels for local drug deliveryAdvanced Drug Delivery Reviews, 2021
- Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone lossActa Biomaterialia, 2021
- Effects of Mesenchymal Stem Cell‐Derived Paracrine Signals and Their Delivery StrategiesAdvanced Healthcare Materials, 2021
- Hypoxia and extracellular vesicles: A review on methods, vesicular cargo and functionsJournal of Extracellular Vesicles, 2020
- Biomaterials Functionalized with MSC Secreted Extracellular Vesicles and Soluble Factors for Tissue RegenerationAdvanced Functional Materials, 2020
- Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126Acta Biomaterialia, 2020
- Exosomes and autophagy: rekindling the vesicular waste hypothesisJournal of Cell Communication and Signaling, 2019